The next milestone in clinical trial of a measurement system developed to diagnose NAFLD
2021 IEEE 21st International Symposium on Computational Intelligence and Informatics (CINTI)(2021)
Abstract
Our publication presents the next important milestone in development of method aimed at the non-destructive diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD). In clinical trials, a specific group of patients (with liver and other carcinomas) were studied. In their case, liver histological examinations are always carried out, which has given us the opportunity to compare bioimpedance spectrum (BIS) data with biopsy results. In our publication, we present the relevant measurement methodology after that we highlight some typical examples that describe the most common pathologies and their associated BIS origins.
MoreTranslated text
Key words
Non-alcoholic Fatty Liver Disease,bioimpedance spectrum measurement,clinical study,new diagnostic method
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined